GlassScriptPhysician profile
Erick Michael Westbroek
NPI 1720423791
$64,317.87
in general payments reported to CMS, 2019-2025
19 companies · $26K in 2025
The $26K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,528 · 2022: $13K · 2023: $7,920 · 2024: $12K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Food and Beverage: $6,940 · Travel and Lodging: $5,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,800.00 |
| Food and Beverage | $6,939.85 |
| Travel and Lodging | $5,815.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $49,419.36 | 2022-2025 | Perla Tl, Perla C, Perla Tl Mis |
| Globus Medical, INC. | $9,108.20 | 2021-2025 | Creo, Aerial, Elsa |
| Spineart Sa | $1,632.33 | 2022 | |
| Nuvasive, INC. | $1,597.09 | 2021-2023 | Simplify Cervical Artificial Disc, Xlif, Reline |
| Integra Lifesciences Corporation | $888.73 | 2023-2025 | Codman Certas, Cusa Clarity, Codman Hakim |
| Biogennix, LLC | $650.00 | 2024 | Agilon Surgical Matrix |
| Medtronic, INC. | $427.38 | 2021 | |
| Spineology INC. | $134.10 | 2021 | |
| Stryker Corporation | $96.31 | 2021-2025 | Na, Universal Neuro 3 |
| Integrity Implants INC. Dba Accelus | $77.07 | 2023 | |
| Neo Spine USA, INC. | $61.85 | 2025 | Neo Pedicle Screw System |
| Abbvie INC. | $42.19 | 2023 | Botox |
| Carbofix Spine INC | $36.12 | 2023 | |
| Alphatec Spine, INC | $31.85 | 2021 | |
| Biocomposites INC | $27.92 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $23.13 | 2024 | Senza |
| Pfizer INC. | $22.73 | 2024 | |
| Ibsa Pharma INC. | $22.20 | 2023 | Tirosint, Licart |
| Bioventus LLC | $19.31 | 2023 | Bonescalpel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erick Westbroek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.